Two experts offer an in-depth look at the challenges and opportunities for integrating mental health into HIV care.

The unidentified man, known in medical spheres as the “Oslo patient,” is now the 10th person worldwide to be in full, ...

When she was a kid in the 1970s, Karen Terio wasn't allowed to watch much television, but wildlife specials were permitted.

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...

After receiving a stem cell transplant from his brother, a 63-year-old Norwegian man known as the "Oslo patient" has become ...

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat.Even with effective antiretroviral therapy, immune ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

A cornerstone of the effort to combat the nation's HIV epidemic is beginning to show fiscal cracks. The Ryan White HIV/AIDS Program has helped more than a quarter million Americans living with HIV to ...

Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the first once-daily single tablet HIV ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...